Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effective Tumor Annotation for Automated Diagnosis of Liver Cancer.

IEEE journal of translational engineering in health and medicine·2025
Same author

Visible-Light-Driven Photocatalytic [3+2]- and [3+2+3]-Annulation Reactions of <i>N</i>-[(Trimethylsilyl)methyl]phthalimide with Electron-Deficient Alkenes and Alkynes.

Organic letters·2025
Same author

Iron-Cobalt Dual Catalysis for the Synthesis of Alkenyl Amino Acids and Modification of Peptides.

Organic letters·2025
Same author

Photosensitized Three-Component Carboimination of Alkenes Based on the Relay of Oxy Radicals to Carbon Radicals.

Organic letters·2024
Same author

Combined Hounsfield units of hepatocellular carcinoma on computed tomography and PET as a noninvasive predictor of early recurrence after living donor liver transplantation: Time-to-recurrence survival analysis.

European journal of radiology·2024
Same author

Psoas muscle area as a predictor of low muscle mass in Asian patients with compensated advanced chronic liver disease.

Clinics and research in hepatology and gastroenterology·2024

Related Experiment Video

Updated: Sep 26, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

289

CoMI: consensus mutual information for tissue-specific gene signatures.

Sing-Han Huang1,2, Yu-Shu Lo1, Yong-Chun Luo1

  • 1Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan.

BMC Bioinformatics
|April 20, 2022
PubMed
Summary
This summary is machine-generated.

We developed consensus mutual information (CoMI) to find tissue-specific gene signatures for early disease diagnosis and prognosis. CoMI effectively identified a 50-gene signature in Glioblastoma Multiforme (GBM) patients, distinguishing high- and low-risk groups.

Keywords:
Omics dataPrognostic gene signatureTissue-specific gene signature

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

542

Related Experiment Videos

Last Updated: Sep 26, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

289
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

542

Area of Science:

  • Genomics
  • Bioinformatics
  • Precision Medicine

Background:

  • Gene signatures are crucial for early disease diagnosis, prognosis, and personalized treatment strategies.
  • Current methods for identifying gene signatures often lack tissue specificity, limiting their clinical utility.
  • Tissue-specific gene signatures are essential for improving diagnostic accuracy and reducing treatment side effects in precision medicine.

Purpose of the Study:

  • To propose a novel method for discovering tissue-specific gene signatures from omics data.
  • To identify differentially expressed genes that reflect both cancer-related and tissue-specific biological processes.
  • To validate the method's ability to identify gene signatures for diagnosis and prognosis.

Main Methods:

  • Developed consensus mutual information (CoMI), a new method for analyzing omics data.
  • Applied CoMI to identify differentially expressed genes across multiple cancer types.
  • Utilized CoMI to discover cancer-related and tissue-specific gene signatures.

Main Results:

  • CoMI successfully identified tissue-specific gene signatures, including "Cell growth and death" in multiple cancers, "Xenobiotics biodegradation and metabolism" in LIHC, and "Nervous system" in GBM.
  • A 50-gene signature identified using CoMI effectively distinguished Glioblastoma Multiforme (GBM) patients into high- and low-risk groups (log-rank p=0.006).
  • The identified gene signatures demonstrated significant diagnostic and prognostic capabilities.

Conclusions:

  • Consensus mutual information (CoMI) is effective in identifying significant and consistent gene signatures with tissue-specific properties.
  • CoMI can accurately predict clinical outcomes for various diseases.
  • The CoMI method provides a valuable tool for omics data analysis and the discovery of disease-specific gene signatures.